scanX
Home
Morepen Laboratories

Morepen Laboratories

77.43
-0.27
(-0.35%)
Market Cap (₹ Cr.)
₹4,241
52 Week High
100.90
Book Value
₹17
52 Week Low
32.55
PE Ratio
36.00
PB Ratio
4.05
PE for Sector
37.27
PB for Sector
4.40
ROE
11.40 %
ROCE
15.61 %
Dividend Yield
0.00 %
EPS
₹2.15
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
19.72 %
Net Income Growth
149.82 %
Cash Flow Change
180.48 %
ROE
121.88 %
ROCE
111.26 %
EBITDA Margin (Avg.)
68.29 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
86
104
113
113
124
121
144
139
148
124
139
143
158
151
162
201
207
190
203
218
191
245
318
293
268
367
372
375
346
275
384
346
340
371
384
398
397
389
Expenses
78
90
97
96
110
108
125
124
131
113
120
125
144
139
146
182
186
170
185
200
173
218
285
260
236
323
333
342
323
261
356
323
321
344
352
344
336
337
EBITDA
8
14
16
17
14
13
19
15
17
12
19
18
15
12
17
19
21
20
18
18
18
27
33
33
32
44
40
33
22
14
28
23
18
27
33
55
60
52
Operating Profit %
5 %
9 %
11 %
12 %
11 %
11 %
13 %
11 %
10 %
8 %
13 %
12 %
9 %
8 %
10 %
8 %
10 %
10 %
7 %
6 %
9 %
10 %
9 %
10 %
10 %
12 %
10 %
8 %
6 %
5 %
7 %
6 %
5 %
7 %
8 %
13 %
14 %
13 %
Depreciation
10
9
9
9
9
8
8
8
8
8
8
8
10
9
9
9
11
11
8
8
8
7
7
7
6
5
6
5
5
4
4
5
5
5
5
6
7
4
Interest
3
2
3
3
3
2
2
2
1
1
1
1
1
0
0
0
1
0
0
1
1
0
0
1
-0
0
-9
1
1
0
0
1
1
0
0
2
1
1
Profit Before Tax
-5
3
4
6
3
3
8
5
7
2
10
10
4
3
7
10
9
8
10
10
9
19
26
25
25
39
43
27
17
10
23
18
13
22
27
47
53
47
Tax
-1
1
1
-2
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
5
0
0
0
0
0
0
8
9
6
-0
3
7
5
2
6
7
12
13
12
Net Profit
-4
3
3
7
3
3
8
5
7
2
10
10
4
2
7
10
9
8
5
10
9
19
26
25
25
31
34
22
14
7
17
13
10
16
20
35
40
35
EPS in ₹
-0.09
0.05
0.07
0.16
0.06
0.09
0.16
0.09
0.17
0.04
0.23
0.21
0.09
0.05
0.16
0.22
0.21
0.19
0.10
0.22
0.21
0.42
0.57
0.55
0.56
0.69
0.77
0.48
0.32
0.14
0.35
0.23
0.20
0.31
0.39
0.69
0.78
0.69
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
500
535
548
591
619
662
847
1,033
1,106
1,279
Fixed Assets
244
216
191
182
153
135
144
156
171
217
Current Assets
104
147
179
227
283
348
493
677
731
843
Capital Work in Progress
0
0
0
0
0
0
2
14
17
24
Investments
0
0
118
118
118
119
119
118
118
126
Other Assets
256
318
239
291
349
408
583
745
800
912
Total Liabilities
187
206
323
340
342
355
403
435
325
390
Current Liabilities
114
151
308
322
321
329
376
403
291
353
Non Current Liabilities
73
55
15
18
21
25
27
32
34
38
Total Equity
313
329
224
251
277
307
445
598
780
889
Reserve & Surplus
103
119
134
161
187
217
355
503
678
787
Share Capital
210
210
90
90
90
90
90
96
102
102
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-5
3
-1
4
3
28
-25
6
-6
Investing Activities
-30
-27
-15
-24
-10
-12
-69
-23
-36
-84
Operating Activities
51
54
49
61
15
11
49
-69
-102
77
Financing Activities
-20
-28
-31
-38
-0
5
47
66
144
0
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Promoter
34.54 %
34.54 %
34.54 %
34.54 %
38.38 %
36.74 %
36.74 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
35.65 %
35.65 %
FIIs
0.68 %
0.68 %
0.86 %
0.91 %
0.96 %
0.93 %
0.95 %
1.16 %
0.88 %
0.96 %
1.00 %
1.29 %
2.11 %
1.85 %
1.67 %
7.72 %
2.08 %
DIIs
2.89 %
2.05 %
1.26 %
1.16 %
1.07 %
4.07 %
4.07 %
3.98 %
3.74 %
2.93 %
2.33 %
2.28 %
2.22 %
2.15 %
2.15 %
2.90 %
1.70 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
61.89 %
62.73 %
63.34 %
63.39 %
59.59 %
58.26 %
58.24 %
56.63 %
57.14 %
57.88 %
58.44 %
58.20 %
57.44 %
57.77 %
57.95 %
53.72 %
60.56 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,871.60 4,48,891.59 40.04 49,887.17 12.06 9,648 27.35 48.75
Cipla
1,477.55 1,19,370.68 25.86 26,520.66 14.17 4,155 12.95 29.94
Mankind Pharma
2,528.70 1,01,256.80 51.60 10,615.63 19.57 1,942 9.89 47.01
Zydus Life Science
1,002.20 1,00,854.83 24.19 19,831.50 13.82 3,831 30.78 35.83
Lupin
2,206.15 1,00,632.06 44.46 20,141.50 19.94 1,936 77.69 53.15
Aurobindo Pharma
1,412.35 82,772.62 23.07 29,559.25 17.55 3,169 61.17 35.29
Alkem Laboratories
5,928.30 70,818.95 32.94 12,978.42 9.84 1,811 91.18 43.24
Glenmark Pharmaceuticals
1,675.10 47,236.89 - 12,653.09 6.58 -1,831 96.52 45.31
IPCA Laboratories
1,585.10 40,199.43 68.47 7,829.81 22.92 529 21.35 54.64
Biocon
327.00 39,241.61 25.14 15,621.20 35.25 1,298 478.78 39.34

Corporate Action

Technical Indicators

RSI(14)
Neutral
41.80
ATR(14)
Less Volatile
4.69
STOCH(9,6)
Oversold
12.90
STOCH RSI(14)
Oversold
15.85
MACD(12,26)
Bearish
-1.30
ADX(14)
Weak Trend
20.41
UO(9)
Bearish
39.70
ROC(12)
Downtrend But Slowing Down
-11.58
WillR(14)
Neutral
-78.61
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.